The application discloses an embedded blood treatment platform architecture
system, which comprises a hardware layer, a hardware and
software abstraction layer, a
service layer and an
application layer; the application is completely decoupled from the hardware through the hardware and
software abstraction layer, the upper-layer
business logic does not need to be repeatedly changed when new equipment is developed or function is upgraded, the development cycle is significantly shortened, the development and iteration cost can be reduced, the MCU procurement risk can be reduced, the MCU core boards of different types and different manufacturers can be replaced, only the bottom-layer driving registration needs to be updated, the
chip supply chain fluctuation can be effectively coped with, new function modules do not need to be re-designed when the hardware modularization slot and the FPGA
dynamic loading circuit are based, the hardware function plug-in is truly realized, the
system expandability is improved, and finally, since the responsibilities of each layer are clear and can be independently verified, the
system integration stage defects can be reduced, the
test complexity is reduced, the development quality and
test efficiency are greatly improved, and the application is suitable for popularization and application in the technical field of
medical equipment.